Date published: 2026-1-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ADAR3 Inhibitors

ADAR3 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Adenosine Deaminase Acting on RNA 3 (ADAR3), an enzyme that plays a key role in RNA editing, a post-transcriptional process that modifies RNA sequences by converting adenosine (A) to inosine (I) within double-stranded RNA regions. ADAR3 is a member of the ADAR family, which is involved in the regulation of gene expression and the diversification of the transcriptome. Unlike its more widely studied counterparts, ADAR1 and ADAR2, ADAR3 is predominantly expressed in the brain and is thought to have a regulatory role, modulating the activity of other ADAR enzymes rather than catalyzing RNA editing directly. ADAR3 is believed to bind to RNA substrates and inhibit editing by competing with ADAR1 and ADAR2, thereby influencing the editing landscape of RNAs involved in neural function and development. By inhibiting ADAR3, researchers can modulate the RNA editing process, providing a valuable tool to study the specific contributions of ADAR3 to RNA metabolism and neural biology.

In research, ADAR3 inhibitors are valuable for exploring the mechanisms of RNA editing and the broader implications of RNA modifications on gene expression and cellular function. By blocking ADAR3 activity, scientists can investigate how the inhibition affects RNA editing patterns, particularly in the context of neural tissue where ADAR3 is most active. This inhibition allows researchers to study the role of ADAR3 in regulating the balance of RNA editing mediated by ADAR1 and ADAR2 and to examine the downstream effects on mRNA splicing, stability, and translation. Additionally, ADAR3 inhibitors enable the investigation of the interactions between ADAR3 and other RNA-binding proteins, providing insights into the complex regulatory networks that govern RNA processing and function in the brain. Through these studies, the use of ADAR3 inhibitors enhances our understanding of the molecular mechanisms underlying RNA editing, the role of ADAR3 in neural gene expression, and the broader implications of RNA modifications in neurobiology and cellular regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Pentostatin

53910-25-1sc-204177
sc-204177A
10 mg
50 mg
$175.00
$702.00
5
(1)

Pentostatin is an inhibitor of adenosine deaminase involved in nucleic acid metabolism, which might indirectly influence ADAR3 function.

Ribavirin

36791-04-5sc-203238
sc-203238A
sc-203238B
10 mg
100 mg
5 g
$63.00
$110.00
$214.00
1
(1)

Ribavirin, a nucleoside analog, may impact RNA editing processes, potentially influencing ADAR3 activity.

2-Chloro-2′-deoxyadenosine

4291-63-8sc-202399
10 mg
$144.00
1
(0)

Cladribine is a nucleoside analog that targets nucleic acid metabolism and may indirectly impact ADAR3 function.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Decitabine, a DNA methyltransferase inhibitor, can alter gene expression and potentially impact pathways involving ADAR3.

Guanabenz acetate

23256-50-0sc-203590
sc-203590A
sc-203590B
sc-203590C
sc-203590D
100 mg
500 mg
1 g
10 g
25 g
$102.00
$468.00
$832.00
$4162.00
$7283.00
2
(2)

Guanabenz, which can affect stress responses in cells, might indirectly impact ADAR3's role in RNA editing.

Temozolomide

85622-93-1sc-203292
sc-203292A
25 mg
100 mg
$91.00
$255.00
32
(1)

Temozolomide, an alkylating agent, can affect nucleic acid integrity and potentially influence ADAR3-related processes.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram can modulate various biochemical pathways, potentially affecting ADAR3's function indirectly.